Single-use Bioprocessing Market

Single-Use Bioprocessing Market Research, 2034

Single-use Bioprocessing Market, valued at USD 28.8 billion in 2023, is expected to expand at a compound annual growth rate (CAGR) of 16.5% over the forecast period from 2024 to 2034, reaching an estimated market size of USD 154.4 billion by 2034.

Single-use bioprocessing involves the use of disposable, pre-sterilized equipment and components for manufacturing biopharmaceutical products. This technology offers significant benefits, such as cost reduction by eliminating the need for cleaning and sterilization between batches, resulting in lower operational costs and reduced downtime. Single-use systems also provide increased flexibility, allowing for easy scaling of production processes to meet changing demands. They help minimize the risk of cross-contamination, enhancing product safety. The rapid setup and processing times associated with disposable equipment accelerate the development and production cycle, leading to a faster time-to-market. The growing demand for biopharmaceuticals is driving the adoption of single-use bioprocessing among biotech and pharmaceutical companies, as well as contract research and manufacturing organizations.

Market Highlights

Single-use Bioprocessing Market is projected to grow at a compound annual growth rate (CAGR) of 16.5% from 2024 to 2034

Single-use Bioprocessing Market is expected to achieve a value of USD 154.4 billion, with a growth rate of 16.5% over the forecast period. The market growth is driven by the cost-effectiveness, operational flexibility, and enhanced product safety offered by single-use systems. The elimination of cleaning and sterilization processes between batches reduces operational costs and downtime. The ability to quickly scale production processes is crucial for meeting the evolving needs of biopharmaceutical development. Moreover, single-use systems reduce the risk of contamination, ensuring product safety. The market is expected to continue growing due to the increasing demand for biopharmaceuticals, advancements in single-use materials and technologies, regulatory support, and the industry's shift towards more agile manufacturing processes.

Single-use Bioprocessing Market Segmentation

Filtration's diverse applications and critical role in biopharmaceutical production make it the dominant segment

Single-use Bioprocessing Market is segmented based on Application into Filtration, Purification, Cell Culture, Mixing, and Others. is a critical aspect of single-use bioprocessing due to its essential role in biopharmaceutical production and diverse applications. It is crucial for both upstream and downstream processes, removing impurities and contaminants to ensure product purity. Filtration serves various purposes, including clarification, sterilization, depyrogenation, purification, and recovery. Technological advancements in membrane and depth filtration technologies have enhanced their effectiveness. Regulatory requirements also drive the need for advanced filtration systems to ensure compliance with safety standards. In bioprocessing, filtration is used for media sterilization, cell removal, clarification, capturing the product, impurity removal, and final product polishing. Cross-flow filtration is widely employed for protein solution concentration and diafiltration.   

Upstream leads the market owing to the process's better scalability and flexibility

Single-use Bioprocessing Market into Workflow into Upstream, Downstream, and Fermentation. Upstream processing currently leads the single-use bioprocessing market due to its critical role in growing and multiplying cell cultures for biopharmaceutical manufacturing. This process requires a variety of consumables, including cell culture media, buffers, and other solutions, necessitating the use of disposable items such as bags, tubing, and bioreactors. During the initial stages of development, biopharmaceutical companies often conduct experiments with different cell lines and culture conditions, leading to frequent process changes and a greater reliance on disposable equipment. Single-use systems offer unparalleled scalability and flexibility in upstream processes, enabling quick adjustments in production volume and process parameters, making them ideal for dynamic and evolving bioprocessing needs.

Market Dynamics

Growth Drivers

Increased Demand and Adoption of Single-Use Systems to Drive Market Growth

Rising demand and adoption of single-use systems are expanding the single-use bioprocessing market. The increased productivity offered by these systems, due to reduced cleaning and sterilization times, leads to faster production cycles and higher output, which is crucial in the rapidly evolving biopharmaceutical sector. The disposable nature of single-use components reduces the risk of cross-contamination, ensuring the purity and safety of products in biologics manufacturing. Single-use systems also offer greater flexibility in process development and scale-up, easily adapting to different product formulations and production volumes. Additionally, they require less capital investment compared to traditional stainless steel equipment, making them attractive to smaller biotech firms and new market entrants.

Rising Investment in Research and Development Activities Are Fueling Market Expansion

Significant investments in research and development (R&D) are driving the growth of the single-use bioprocessing market. Advances in bioprocessing technologies are facilitating the development of new biologics, such as monoclonal antibodies and cell therapies. Single-use systems provide the necessary precision and flexibility for these complex processes. R&D efforts focus on improving efficiency, yield, and product quality through process optimization, leveraging single-use systems for rapid experimentation. Investing in R&D also fosters technological advancements, resulting in innovative single-use components and systems that expand the market's capabilities and applications. Moreover, disposable systems enable faster process development and scale-up, accelerating the time to market for new biopharmaceuticals. 

Restraints

Stringent Regulatory Laws to Create Challenges for Market Growth

Stringent regulatory laws pose a significant challenge to the growth of the single-use bioprocessing market. These regulations are designed to ensure product safety and efficacy, enforcing strict quality standards and compliance requirements. The complex validation processes for sterility, biocompatibility, and performance require significant time and resources, leading to delays in product launches and higher development costs. Smaller companies often struggle with understanding and complying with evolving regulations, necessitating substantial expertise and financial resources. Strict regulatory compliance also increases manufacturing costs due to extensive documentation, quality control procedures, and specialized personnel, reducing profitability. Regulatory constraints on materials can hinder innovation, and varying requirements across different countries add to the operational complexity and administrative burden. Despite these challenges, the industry continues to invest in robust quality control systems and measures to minimize risks and ensure regulatory compliance.

Recent Developments

• In 2023-24, Thermo Fisher Scientific Inc. introduced the Thermo Scientific HyPerforma DynaDrive Single-Use Bioreactor, designed for large-scale production. The company also acquired BioProcess Technology Consultants to expand its single-use solutions portfolio.
• In 2023-24, Danaher Corporation launched the Pall Allegro™ STR Single-Use Bioreactor for enhanced scalability and flexibility. The company formed a partnership with Cytiva to co-develop innovative single-use technologies.
• In 2023-24, Sartorius AG released the Sartorius Biostat STR® Generation 3 Single-Use Bioreactor for improved process efficiency. The company also completed the acquisition of BIA Separations to enhance its purification capabilities for single-use systems.
• In 2023-24, Merck KGaA introduced the Mobius MyWay Portfolio, offering customizable single-use solutions. The company has significantly focused on expanding its M Lab Collaboration Centers to support the development of single-use technologies.
• In 2023-24, GE Healthcare introduced the Sefia™ S-2000, a single-use technology for cell therapy manufacturing. The company also partnered with the National Institute for Bioprocessing Research and Training (NIBRT) to advance single-use bioprocessing training.

Key Players:

• Thermo Fisher Scientific Inc.
• (Cytiva) Danaher Corporation
• Sartorius AG
• Merck KGaA
• GE Healthcare
• Eppendorf AG
• Corning Incorporated
• Saint-Gobain
• Parker Hannifin Corporation
• 3M
• Meissner Filtration Products, Inc.
• CESCO Bioengineering Co., Ltd.
• Rentschler Biopharma SE
• Entegris, Inc.
• Kuhner AG
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Single-use Bioprocessing Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America holds a dominant position in the single-use bioprocessing market attributed to various important reasons. The region boasts a significant number of top biopharmaceutical firms, fueling a substantial need for disposable systems. Having been quick to embrace these technologies, North America has cultivated a stable and advanced market. Substantial investments in research and development have promoted notable innovation in single-use bioprocessing. Moreover, a somewhat simplified regulatory landscape has also helped boost market expansion.

Single-use Bioprocessing Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Single-use Bioprocessing Market Scope and Segments:

Frequently Asked Questions (FAQ):